Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-16

Clinical Trial Update: A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SYMBICORT inhaler (budesonide/formoterol) with Formoterol Turbuhaler in chronic obstructive pulmonary disease. Results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Formoterol Turbuhaler (formoterol)
  • Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-09-16